BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25247971)

  • 1. In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.
    Childs DD; Clingan MJ; Zagoria RJ; Sirintrapun J; Tangtiang K; Anderson A; Leyendecker JR
    AJR Am J Roentgenol; 2014 Oct; 203(4):W421-8. PubMed ID: 25247971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
    Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
    AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
    Rosenkrantz AB; Wehrli NE; Melamed J; Taneja SS; Shaikh MB
    Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma.
    Kierans AS; Rusinek H; Lee A; Shaikh MB; Triolo M; Huang WC; Chandarana H
    AJR Am J Roentgenol; 2014 Dec; 203(6):W637-44. PubMed ID: 25415729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors.
    Sevcenco S; Heinz-Peer G; Ponhold L; Javor D; Kuehhas FE; Klingler HC; Remzi M; Weibl P; Shariat SF; Baltzer PA
    Eur J Radiol; 2014 Jun; 83(6):909-913. PubMed ID: 24709332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material.
    Akita H; Jinzaki M; Akita A; Mikami S; Oya M; Kuribayashi S
    J Magn Reson Imaging; 2014 Apr; 39(4):924-30. PubMed ID: 24123320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
    Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
    Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
    Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 3D two-point Dixon and standard 2D dual-echo breath-hold sequences for detection and quantification of fat content in renal angiomyolipoma.
    Rosenkrantz AB; Raj S; Babb JS; Chandarana H
    Eur J Radiol; 2012 Jan; 81(1):47-51. PubMed ID: 21126839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?
    Hindman N; Ngo L; Genega EM; Melamed J; Wei J; Braza JM; Rofsky NM; Pedrosa I
    Radiology; 2012 Nov; 265(2):468-77. PubMed ID: 23012463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MR imaging features of different renal cell carcinoma subtypes].
    Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of renal cell carcinoma: its role in determining cell type.
    Yoshimitsu K; Irie H; Tajima T; Nishie A; Asayama Y; Hirakawa M; Nakayama T; Kakihara D; Honda H
    Radiat Med; 2004; 22(6):371-6. PubMed ID: 15648450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images.
    Outwater EK; Bhatia M; Siegelman ES; Burke MA; Mitchell DG
    Radiology; 1997 Oct; 205(1):103-7. PubMed ID: 9314970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI of solid renal masses: pearls and pitfalls.
    Ramamurthy NK; Moosavi B; McInnes MD; Flood TA; Schieda N
    Clin Radiol; 2015 Mar; 70(3):304-16. PubMed ID: 25472466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.